Repurposed drug may extend survival in aggressive ovarian cancer, trial shows

This is a live story built from multiple sources. It may evolve quickly.

Coverage meter • 1 min window

Back to home Open top source

T theguardian.com

What’s included

Top recent items from this story.

1 items • 1 unique links

The Guardian - Science 1 day ago • theguardian.com

Repurposed drug may extend survival in aggressive ovarian cancer, trial shows

Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant casesA drug originally used to treat a rare disease could extend the lives of patients with an aggressive form of ova…

Open